Cost-Utility Analysis of Incobotulinumtoxin-A Compared With Conventional Therapy in the Management of Post-Stroke Spasticity in Romania
Objectives: In Romania, the strokes’ incidence is of 61,500 per year and improving upper limb function is the essence in rehabilitation after a stroke to maximize the patient quality of life and reduce disability. In this study, it is compared the cost-effectiveness of the treatment of post-stroke u...
Main Authors: | Adina Turcu-Stiolica, Mihaela-Simona Subtirelu, Ana-Maria Bumbea |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01516/full |
Similar Items
-
Can Incobotulinumtoxin-A Treatment Improve Quality of Life Better Than Conventional Therapy in Spastic Muscle Post-Stroke Patients? Results from a Pilot Study from a Single Center
by: Adina Turcu-Stiolica, et al.
Published: (2021-07-01) -
Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis
by: Petr Kaňovský, et al.
Published: (2021-01-01) -
Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
by: Klemens Fheodoroff, et al.
Published: (2020-03-01) -
Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
by: Santamato A
Published: (2016-01-01) -
Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA
by: Jörg Wissel, et al.